Generate a tailored SOP for Dr. Barbara Harper. Improve your application with a focused, well-structured draft.
Barbara Kemp-Harper is a vascular pharmacologist whose research focuses on improving blood vessel function in conditions such as hypertension, high cholesterol, and diabetes. She is a Senior Lecturer in the Department of Pharmacology at Monash University and leads the Vascular Biology Immunopharmacology Group. Barbara's research is particularly centered around the mechanisms underlying blood vessel dysfunction in cardiovascular disease, with a strong interest in nitric oxide, a biologically active gas produced in blood vessels that helps maintain adequate blood flow and blood pressure. Barbara's work aims to identify new therapeutic strategies to overcome nitric oxide dysfunction and has gained international recognition for her research on nitroxyl, a novel sibling of nitric oxide. Her contributions have led to the identification of potential nitroxyl-like drugs for the treatment of conditions such as angina and high blood pressure. Barbara is actively involved in projects aligned with the UN Sustainable Development Goals, emphasizing her commitment to addressing global health challenges.
Monash University • Melbourne, VIC, Australia
Associate Professor in Pharmacology focusing on vascular pharmacology and related research areas.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.